離心式血液幫浦市場規模、佔有率和成長分析：按產品類型、應用、最終用戶、通路和地區分類－2026-2033年產業預測

2024 年全球離心式血液幫浦市場價值為 5.825 億美元，預計到 2033 年將從 2025 年的 6.2397 億美元成長到 10.854 億美元，預測期（2026-2033 年）的複合年成長率為 7.12%。

受心肺體外迴圈。近期技術進步顯著降低了溶血和血栓症形成的風險，隨著監測能力和治療效果的提升，醫療專業人員越來越傾向於在加護病房（ICU）的複雜手術中使用這些設備。人口老化和心臟衰竭的高發病率進一步推動了市場需求，製造商正在加強生產能力、加大研發投入並建立戰略合作夥伴關係，以掌握新的市場機會。

全球離心式血液幫浦市場的成長要素

全球離心式血泵市場的主要驅動力在於泵體設計、材料和控制系統的進步。這些進步顯著提高了設備的可靠性、血液相容性以及與臨床工作流程的無縫整合。這些改進緩解了人們對設備耐用性和併發症風險的擔憂，促進了臨床醫生的接受和醫院的採購，並最終有助於制定長期治療方案。因此，對新一代血泵的需求不斷成長。製造商正利用這些技術進步來實現產品差異化並拓展應用領域。更安全、更可預測的績效正在增強相關人員的信心，並最終推動市場的持續成長。

全球離心式血液幫浦市場的限制因素

全球離心式血泵市場面臨許多挑戰，其中最主要的原因是先進離心式血泵系統部署和維修成本高。這會阻礙小規模醫院和資源有限的醫療機構採用這些系統，最終影響市場成長。預算限制和各種財務優先事項往往導致採購負責人選擇更經濟實惠的替代方案或延遲升級。同時，由於缺乏全面的療效數據和訓練投入，難以有效證明這些血泵的長期效益。這些經濟障礙導致採購週期延長，限制了能夠廣泛採用這些技術的醫療機構數量，阻礙了整體市場擴張。

全球離心式血泵市場趨勢

受設備工程和材料科學進步的推動，全球離心式血泵市場正呈現小型化和門診應用的顯著趨勢。隨著離心式血泵體積更小、重量更輕，其設計越來越注重提升患者的活動能力和支持門診治療，從而改善患者的生活品質。製造商優先考慮符合人體工學的設計和便利的植入流程，以確保長期佩戴的舒適性。此外，減少血栓形成表面和降低噪音水平的努力也提高了患者的舒適度和治療依從性。這一轉變與更廣泛的醫療保健趨勢相契合，即在保持高水平臨床安全性和療效的同時，促進從住院治療向門診治療的過渡。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球離心式血液幫浦市場規模：依產品類型分類

• 外置離心式幫浦
• 內建離心式幫浦

全球離心式血液幫浦市場規模：依應用領域分類

• 心肺體外迴圈（CPB）
• ECMO（體外膜氧合）
• 心室輔助裝置（VAD）

全球離心式血液幫浦市場規模：依最終用戶分類

• 醫院（心臟外科）
• 加護病房
• 研究機構

全球離心式血液幫浦市場規模：依通路分類

• 直銷
• 銷售代理

全球離心式血液幫浦市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic plc
• Abbott Laboratories（HeartMate）
• Thoratec（Abbott）
• Getinge AB
• LivaNova plc
• Terumo Cardiovascular
• Fresenius Medical Care
• Xenios AG（Fresenius）
• Eurosets srl
• Braile Biomedica
• MAQUET（Getinge）
• Biomedicus（Medtronic）
• Sorin Group（LivaNova）
• CryoLife Inc.
• Nikkiso Co. Ltd.
• TandemHeart（LivaNova）
• CorWave SA
• Calon Cardio-Technology
• BiVACOR Inc.
• Evaheart Inc.

結論與建議

Global Centrifugal Blood Pumps Market size was valued at USD 582.5 Million in 2024 and is poised to grow from USD 623.97 Million in 2025 to USD 1085.4 Million by 2033, growing at a CAGR of 7.12% during the forecast period (2026-2033).

The centrifugal blood pumps market is poised for significant growth, driven by the rising incidence of cardiovascular diseases and the increasing reliance on extracorporeal circulation for surgical and long-term mechanical support. These pumps are categorized as either implantable or extracorporeal devices, utilizing rotating impellers to ensure low shear blood flow during critical medical procedures such as cardiopulmonary bypass and ECMO. Recent technological advancements have greatly minimized risks associated with hemolysis and thrombosis, prompting healthcare professionals to favor these devices in complex ICU procedures due to improved monitoring and outcomes. The aging population and high heart failure prevalence further stimulate demand, prompting manufacturers to enhance production, invest in research and development, and forge strategic partnerships to capitalize on emerging market opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Centrifugal Blood Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Centrifugal Blood Pumps Market Segments Analysis

Global centrifugal blood pumps market is segmented by product type, application, end-user, distribution and region. Based on product type, the market is segmented into Extracorporeal Centrifugal Pumps and Implantable Centrifugal Pumps. Based on application, the market is segmented into Cardiopulmonary Bypass (CPB), ECMO (Extracorporeal Membrane Oxygenation) and Ventricular Assist Devices (VAD). Based on end-user, the market is segmented into Hospitals (Cardiac Surgery), Intensive Care Units and Research Institutes. Based on distribution, the market is segmented into Direct Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Centrifugal Blood Pumps Market

The Global Centrifugal Blood Pumps market is primarily driven by advancements in pump design, materials, and control systems, which significantly enhance device reliability, hemocompatibility, and seamless integration into clinical workflows. These improvements encourage greater clinician adoption and hospital procurement by addressing concerns related to durability and complication risks, thereby facilitating longer-term therapy planning. As a result, demand for next-generation pumps rises. Manufacturers capitalize on these technological enhancements to differentiate their offerings and broaden application areas. Their ability to showcase safer, more predictable performance instills greater confidence among stakeholders, ultimately contributing to the continuous growth of the market.

Restraints in the Global Centrifugal Blood Pumps Market

The Global Centrifugal Blood Pumps market faces significant challenges due to high acquisition and maintenance costs linked to advanced centrifugal blood pump systems, which can deter adoption in smaller hospitals and resource-limited healthcare environments, ultimately hindering market growth. Budget constraints and competing financial priorities often lead procurement teams to opt for more affordable alternatives or postpone upgrades, while effectively demonstrating the long-term benefits of these pumps becomes challenging without comprehensive outcome data and training investments. These economic obstacles contribute to prolonged purchasing cycles and limit the number of institutions capable of widely adopting such technologies, consequently stifling overall market expansion.

Market Trends of the Global Centrifugal Blood Pumps Market

The Global Centrifugal Blood Pumps market is witnessing a significant trend towards miniaturization and ambulatory use, driven by advancements in device engineering and materials science. As centrifugal blood pumps become smaller and lighter, they are increasingly designed to facilitate patient mobility and support ambulatory care, thereby enhancing quality of life. Manufacturers are prioritizing ergonomic designs and user-friendly implantation processes to ensure long-term wearability. Additionally, efforts to minimize thrombogenic surfaces and noise levels are enhancing patient comfort and adherence. This shift aligns with broader healthcare trends favoring transitions from inpatient to outpatient settings while maintaining high standards of clinical safety and performance.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Centrifugal Blood Pumps Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Extracorporeal Centrifugal Pumps
• Implantable Centrifugal Pumps

Global Centrifugal Blood Pumps Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cardiopulmonary Bypass (CPB)
• ECMO (Extracorporeal Membrane Oxygenation)
• Ventricular Assist Devices (VAD)

Global Centrifugal Blood Pumps Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals (Cardiac Surgery)
• Intensive Care Units
• Research Institutes

Global Centrifugal Blood Pumps Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors

Global Centrifugal Blood Pumps Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End-User, Distribution)
  • US
  • Canada
• Europe (Product Type, Application, End-User, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-User, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-User, Distribution)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-User, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (HeartMate)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thoratec (Abbott)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Cardiovascular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xenios AG (Fresenius)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurosets srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MAQUET (Getinge)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomedicus (Medtronic)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin Group (LivaNova)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TandemHeart (LivaNova)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorWave SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Calon Cardio-Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evaheart Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations